Hoya Corp (HOCPY)
116.72
-0.77
(-0.65%)
USD |
OTCM |
Apr 26, 12:58
Hoya Cash and Short Term Investments (Quarterly): 3.334B for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 3.334B |
September 30, 2023 | 3.260B |
June 30, 2023 | 3.293B |
March 31, 2023 | 3.199B |
December 31, 2022 | 3.188B |
September 30, 2022 | 3.007B |
June 30, 2022 | 3.140B |
March 31, 2022 | 3.495B |
December 31, 2021 | 3.672B |
September 30, 2021 | 3.498B |
June 30, 2021 | 3.175B |
March 31, 2021 | 3.071B |
December 31, 2020 | 3.097B |
September 30, 2020 | 3.208B |
June 30, 2020 | 2.814B |
March 31, 2020 | 2.954B |
December 31, 2019 | 2.809B |
September 30, 2019 | 2.779B |
June 30, 2019 | 2.562B |
March 31, 2019 | 2.674B |
December 31, 2018 | 2.478B |
September 30, 2018 | 2.364B |
June 30, 2018 | 2.091B |
March 31, 2018 | 2.360B |
December 31, 2017 | 2.081B |
Date | Value |
---|---|
September 30, 2017 | 2.212B |
June 30, 2017 | 2.861B |
March 31, 2017 | 2.814B |
December 31, 2016 | 2.500B |
September 30, 2016 | 2.554B |
June 30, 2016 | 2.565B |
March 31, 2016 | 2.645B |
December 31, 2015 | 2.843B |
September 30, 2015 | 3.050B |
June 30, 2015 | 2.816B |
March 31, 2015 | 3.073B |
December 31, 2014 | 2.908B |
September 30, 2014 | 2.820B |
June 30, 2014 | 2.941B |
March 31, 2014 | 3.319B |
December 31, 2013 | 3.012B |
September 30, 2013 | 2.638B |
June 30, 2013 | 2.749B |
March 31, 2013 | 2.741B |
December 31, 2012 | 2.610B |
September 30, 2012 | 2.550B |
June 30, 2012 | 2.259B |
March 31, 2012 | 3.062B |
December 31, 2011 | 2.977B |
September 30, 2011 | 2.952B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.562B
Minimum
Jun 2019
3.672B
Maximum
Dec 2021
3.134B
Average
3.175B
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 2.251B |
Nxera Pharma Co Ltd | 350.16M |
PeptiDream Inc | 138.37M |
Stemcell Holdings Inc | 5.116M |
Healios KK | 47.67M |